Article
Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value.
Digestion - 1 Jan 2002
Glas J, Török H-P, Vilsmaier F, Herbinger K-H, Hoelscher M, Folwaczny C
Abstract excerpt
Anti-Saccharomyces cerevisiae antibodies (ASCA) have been described as specific markers in Crohn's disease and their healthy first-degree relatives. 171 patients with Crohn's disease, their 105 first-degree relatives, 145 patients with ulcerative colitis and 101 first-degree relatives of patients with ulcerative colitis, 50 patients with infectious enterocolitis and 100 healthy controls were tested for ASCA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.